Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Cancian

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Acta Dermato-Venereologica|June 9, 2016
Living with Chronic Spontaneous Urticaria in Italy: A Narrative Medicine Project to Improve the Pathway of Patient CareAntonietta Cappuccio, Tommaso Limonta, Aurora Parodi, et al.
Lancet (London, England)|February 11, 2023
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trialEmel Aygören-Pürsün, Andrea Zanichelli, Danny M Cohn, et al.
The Lancet. Haematology|March 22, 2026
Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trialEmel Aygören-Pürsün, Marcin Stobiecki, Anna Valerieva, et al.
The New England Journal of Medicine|July 26, 2018
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary AngioedemaEmel Aygören-Pürsün, Anette Bygum, Vesna Grivcheva-Panovska, et al.
Allergy|January 30, 2026
International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary AngioedemaHenriette Farkas, Inmaculada Martinez-Saguer, Konrad Bork, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
Clinical Reviews in Allergy & Immunology|March 7, 2025
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and TreatmentBruce L Zuraw, Konrad Bork, Laurence Bouillet, et al.
Clinical and Translational Allergy|May 21, 2026
The Neglected Older Adults in Hereditary Angioedema: Insights From the ITACA RegistryFrancesca Perego, Azzurra Cesoni Marcelli, Riccardo Senter, et al.
The Journal of Allergy and Clinical Immunology. Global|July 12, 2026
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-STamar Kinaciyan, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Acta Dermato-Venereologica|June 9, 2016
Living with Chronic Spontaneous Urticaria in Italy: A Narrative Medicine Project to Improve the Pathway of Patient CareAntonietta Cappuccio, Tommaso Limonta, Aurora Parodi, et al.
Lancet (London, England)|February 11, 2023
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trialEmel Aygören-Pürsün, Andrea Zanichelli, Danny M Cohn, et al.
The Lancet. Haematology|March 22, 2026
Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trialEmel Aygören-Pürsün, Marcin Stobiecki, Anna Valerieva, et al.
The New England Journal of Medicine|July 26, 2018
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary AngioedemaEmel Aygören-Pürsün, Anette Bygum, Vesna Grivcheva-Panovska, et al.
Allergy|January 30, 2026
International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary AngioedemaHenriette Farkas, Inmaculada Martinez-Saguer, Konrad Bork, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
Clinical Reviews in Allergy & Immunology|March 7, 2025
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and TreatmentBruce L Zuraw, Konrad Bork, Laurence Bouillet, et al.
Clinical and Translational Allergy|May 21, 2026
The Neglected Older Adults in Hereditary Angioedema: Insights From the ITACA RegistryFrancesca Perego, Azzurra Cesoni Marcelli, Riccardo Senter, et al.
The Journal of Allergy and Clinical Immunology. Global|July 12, 2026
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-STamar Kinaciyan, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.
Pageof 5